Adline Chem Lab Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Adline Chem Lab Ltd is ₹ 11.28 as of 20 Apr 15:30 . The P/E Ratio of Adline Chem Lab Ltd changed from 5.3 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 years The Market Cap of Adline Chem Lab Ltd changed from ₹ 2.98 crore on March 2021 to ₹ 7.76 crore on March 2025 . This represents a CAGR of 21.10% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 years The Revenue of Adline Chem Lab Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 . The EBITDA of Adline Chem Lab Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 . The Net Profit of Adline Chem Lab Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 . The Dividend Payout of Adline Chem Lab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Adline Chem Lab Ltd

Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari.
The Company name was changed from Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021.
Adline is a dynamic and innovative multinational company specializing in providing integrated solutions and services across diverse industries.
It is engaged in manufacturing of pharmaceutical chemicals, fine chemicals, agrochemical products.
ADLINE's mission is to revolutionize the industries it serves by providing unparalleled excellence in chemicals, laboratory and lab products establishment, active pharmaceutical ingredients (API), pharmaceuticals, agro/agro trade, biotech, and fertilizers. In May 1990, the Company started production at its site in Rakanpur, Gujarat.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Adline Chem Lab Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Adline Chem Lab Ltd or Vaishali Pharma Ltd?

Market cap of Adline Chem Lab Ltd is 6 Cr while Market cap of Vaishali Pharma Ltd is 99 Cr

What are the key factors driving the stock performance of Adline Chem Lab Ltd and Vaishali Pharma Ltd?

The stock performance of Adline Chem Lab Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Adline Chem Lab Ltd and Vaishali Pharma Ltd?

As of May 4, 2026, the Adline Chem Lab Ltd stock price is INR ₹11.28. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.61.

How do dividend payouts of Adline Chem Lab Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Adline Chem Lab Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.